Given the activation of interferon-related pathways in vitro, decreased macrophage CD206 by both triterpenoids (CDDO-Me and omaveloxolone) in vivo further implicates macrophages in the mechanism of triterpenoid anti-tumor efficacy. This evidence concerns the gene MRC1 and neoplasm.